BANK OF AMERICA CORP /DE/ - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$5,934
+16.6%
4,0000.0%0.00%
Q2 2023$5,090
-24.1%
4,000
-20.0%
0.00%
Q1 2023$6,708
+325.6%
5,000
+400.0%
0.00%
Q4 2022$1,576
+57.6%
1,0000.0%0.00%
Q3 2022$1,000
-90.0%
1,000
-87.5%
0.00%
Q2 2022$10,000
+900.0%
8,000
+700.0%
0.00%
Q1 2022$1,000
-99.8%
1,000
-99.8%
0.00%
Q4 2021$592,000
+59100.0%
475,000
+47400.0%
0.00%
Q1 2021$1,000
-87.5%
1,000
-83.3%
0.00%
Q3 2020$8,000
-20.0%
6,0000.0%0.00%
Q2 2020$10,000
-99.8%
6,000
-99.9%
0.00%
-100.0%
Q1 2020$6,151,000
+2.5%
4,800,000
+22.5%
0.00%0.0%
Q4 2019$6,000,000
+8.0%
3,918,000
-3.4%
0.00%0.0%
Q3 2019$5,554,000
+69325.0%
4,056,000
+67500.0%
0.00%
Q1 2019$8,000
-100.0%
6,000
-100.0%
0.00%
-100.0%
Q4 2018$16,430,000
-48.0%
13,763,000
-25.7%
0.00%
-40.0%
Q3 2018$31,579,000
+301.5%
18,526,000
+239.9%
0.01%
+400.0%
Q2 2018$7,865,0005,450,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
III Capital Management 12,500,000$17,262,0003.12%
CSS LLC/IL 24,395,000$33,616,0001.59%
Mint Tower Capital Management B.V. 9,000,000$12,407,0001.46%
Context Partners Fund, L.P. 3,000,000$4,125,0000.90%
Context Capital Management, LLC 3,000,000$4,125,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 4,258,000$5,971,0000.71%
SSI INVESTMENT MANAGEMENT LLC 5,888,000$8,100,0000.70%
Aequim Alternative Investments LP 3,000,000$4,155,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 32,181,000$44,437,0000.40%
TWO SIGMA SECURITIES, LLC 13,000,000$17,875,0000.36%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders